Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years
Condition: Chikungunya Virus Interventions: Biological: CHIKV VLP/adjuvant; Biological: Placebo Sponsors: Emergent BioSolutions; Catalyst Clinical Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials